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Visuomotor integration deficits are common
to familial and sporadic preclinical Alzheimer’s
disease
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We investigated whether subtle visuomotor deficits were detectable in familial and sporadic preclinical Alzheimer’s disease. A cir-
cle-tracing task—with direct and indirect visual feedback, and dual-task subtraction—was completed by 31 individuals at 50%
risk of familial Alzheimer’s disease (19 presymptomatic mutation carriers; 12 non-carriers) and 390 cognitively normal older adults
(members of the British 1946 Birth Cohort, all born during the same week; age range at assessment ¼ 69–71 years), who also
underwent b-amyloid-PET/MRI to derive amyloid status (positive/negative), whole-brain volume and white matter hyperintensity
volume. We compared preclinical Alzheimer’s groups against controls cross-sectionally (mutation carriers versus non-carriers;
amyloid-positive versus amyloid-negative) on speed and accuracy of circle-tracing and subtraction. Mutation carriers (mean 7 years
before expected onset) and amyloid-positive older adults traced disproportionately less accurately than controls when visual feed-
back was indirect, and were slower at dual-task subtraction. In the older adults, the same pattern of associations was found when
considering amyloid burden as a continuous variable (Standardized Uptake Value Ratio). The effect of amyloid was independent
of white matter hyperintensity and brain volumes, which themselves were associated with different aspects of performance: greater
white matter hyperintensity volume was also associated with disproportionately poorer tracing accuracy when visual feedback was
indirect, whereas larger brain volume was associated with faster tracing and faster subtraction. Mutation carriers also showed evi-
dence of poorer tracing accuracy when visual feedback was direct. This study provides the first evidence of visuomotor integration
deficits common to familial and sporadic preclinical Alzheimer’s disease, which may precede the onset of clinical symptoms by sev-
eral years.
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Introduction
Visuomotor integration describes the ability to combine
visual information with motor output. Although visuo-
motor integration difficulties have received relatively little
attention in Alzheimer’s disease—compared to the well-
established impairments in memory, orientation and
executive functions—deficits have been observed in
Alzheimer’s patients and individuals at high Alzheimer’s
disease risk, particularly under conditions where visual
feedback is indirect (e.g. transformed with respect to the
plane of movement) (Tippett and Sergio, 2006; Tippett
et al., 2007; Hawkins and Sergio, 2014, 2016; Hawkins
et al., 2015; Bartoli et al., 2017; Rogojin et al., 2019).
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It has been proposed that the early emergence of such
deficits in Alzheimer’s disease may be linked to the vul-
nerability of the posterior parietal cortex—a region
understood to be particularly important for co-ordinating
information about eye and hand movements (Tippett and
Sergio, 2006; Hawkins and Sergio, 2014). Furthermore,
visuomotor integration tasks are inherently multi-modal
and multi-tasking in nature, posing a higher-order cogni-
tive challenge in common with other neuropsychological
tests that have shown sensitivity to early decline, such as
the commonly used Digit-Symbol test [e.g. Mormino
et al. (2017)].
However, there has been little investigation of whether
subtle changes in visuomotor integration are detectable
during the preclinical stages of Alzheimer’s disease—
which may extend two to three decades before symptom
onset (Villemagne et al., 2013; McDade et al., 2018)—
and how these may relate to accumulation of pathology.
It is also unclear whether common visuomotor deficits
emerge in the preclinical stages of familial (autosomal
dominant) and sporadic Alzheimer’s disease, given the
different age profiles of these two populations and on-
going debates about the extent of pathological and
phenotypic differences between them [e.g. motor abnor-
malities such as myoclonus (Joshi et al., 2012; Day et al.,
2016; Ryan et al., 2016)].
Using a computerized circle-tracing task that has
detected visuomotor integration deficits in presympto-
matic Huntington’s disease up to a decade before
expected symptom onset (Say et al., 2011), we investi-
gated whether similar subtle deficits were present in two
preclinical Alzheimer’s groups—presymptomatic familial
Alzheimer’s disease (FAD) mutation carriers, and cogni-
tively normal older adults with b-amyloid pathology. We
hypothesized that these groups would trace less accurate-
ly than controls, particularly when visual feedback was
indirect (requiring spatial transformation between planes).
We also aimed to investigate associations between task
performance and other neuroimaging measures: whole-
brain volume and white matter hyperintensity volume
[WMHV, a marker of cerebral small vessel disease (Sudre
et al., 2015)].
Materials and methods
Thirty-one asymptomatic individuals (Clinical Dementia
Rating ¼ 0) at 50% risk of FAD (due to having an
affected parent with a mutation in the PSEN1 or APP
gene) were assessed between February 2015 and March
2016 as part of a longitudinal FAD study at University
College London (O’Connor et al., 2020). Participants
underwent genetic testing to determine mutation status,
but the results were available only to statisticians; partici-
pants and study staff remained blind to mutation status.
As mutation carriers are expected to develop symptoms
at around the same age as their affected parent, years to
expected onset was calculated by subtracting the age that
a participant’s affected parent developed symptoms (based
on a semi-structured interview of family members) from
the participant’s current age. Thus, a larger negative
value indicates greater years before expected onset. No
participants had evidence of any movement disorder on
neurological examination.
Between May 2015 and January 2018, 502 members
of the MRC National Survey of Health and Development
(also known as the British 1946 Birth Cohort; all born
during the same week in March 1946) were assessed at
University College London for the Insight 46 sub-study.
Recruitment and assessment protocols have been pub-
lished previously (Lane et al., 2017; James et al., 2018).
In brief, participants underwent clinical examination, neu-
roimaging (combined MRI and b-amyloid PET) and a
multi-domain neuropsychological battery comprising
standard paper-and-pencil tests and more novel computer-
ized tasks (Lane et al., 2017; Lu et al., 2019, 2020). This
analysis included all cognitively normal participants with
complete neuroimaging data and no clinical tremor dis-
order [n¼ 390, see criteria for normal cognition and rea-
sons for missing neuroimaging data in Lu et al. (2019)].
Both studies were approved by London Queen Square
Research Ethics Committee. All participants provided
written informed consent according to the declaration of
Helsinki.
We use the short-hand term ‘preclinical groups’ to refer
to FAD mutation carriers and amyloid-positive Insight 46
participants (see definition of amyloid-positivity), but note
the non-equivalence of these two groups in terms of
prognosis: FAD mutations are almost fully penetrant,
whereas amyloid-positivity in older adults indicates
increased risk of Alzheimer’s disease but it is not an ac-
curate predictor on an individual basis (Brookmeyer and
Abdalla, 2018).
Circle-tracing task
The circle-tracing task was presented on a Lenovo
ThinkPad-X61 tablet with an additional monitor (Fig. 1).
Participants were instructed to trace clockwise round the
circle using a stylus as quickly and accurately as possible,
with their dominant hand. A thin line appeared to show
their tracing path. In the direct condition, participants
could see their hand and their tracing path on the tablet.
In the indirect condition, the tablet was covered by a box
with the front open to allow participants to put their
hand inside, and participants wore a cape covering the
arms, and hence they had no direct visual feedback but
could view a copy of the circle and the tracing path on
the monitor. Each trial lasted 45 s.
In the FAD study, 12 trials were administered (ordered
DDDIIIDDDIII; D¼direct, I¼indirect). The last six trials
included dual-task serial subtraction similar to the previ-
ously published studies (Vaportzis et al., 2014, 2015):
participants were asked to count backwards in threes
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(starting from 99, 98, 97, 96, 95 and 94). If they reached
zero or near zero, they were instructed to begin again
from the starting number. No instructions were given
about whether to prioritize the circle-tracing or the serial
subtraction task. For Insight 46, a 6-trial version was
administered (DIIDDI) with dual-task subtraction during
all trials. This shorter version does not permit evaluation
of dual-task costs, but it allowed us to administer the
most challenging version of circle-tracing within our time
constraints. The order of trials was chosen to allow par-
ticipants to familiarize themselves first with the easier dir-
ect condition [as described the in previously published
studies (Vaportzis et al., 2014, 2015)].
The following trial-by-trial outcomes were derived:
• Number of rotations (index of tracing speed).
• Number of errors per rotation (index of tracing accur-
acy). An error was recorded whenever the stylus devi-
ated outside the annulus for >100 ms.
• Subtraction rate (responses per second).
• Number of incorrect subtractions.
Insight 46 variables
As previously described (Lane et al., 2017, 2019), b-
amyloid-PET and multi-modal MRI data were collected
during a 60-min scanning session on a single Biograph
mMR 3 T-PET/MRI scanner (Siemens Healthcare,
Erlangen), with intravenous injection of 370 MBq of
18 F-Florbetapir (Amyvid). b-Amyloid deposition was
quantified using the Standardized Uptake Value Ratio
(SUVR), with a cut-point for Ab-positivity at SUVR
>0.6104. Whole-brain volume was generated from 3D
T1-weighted MRI using automated segmentation with
manual editing (Leung et al., 2011). Total intracranial
volume was generated using statistical parametric map-
ping (SPM12; http://www.fil.ion.ucl.ac.uk/spm; accessed
29 January 2021) (Malone et al., 2015). Global WMHV
was generated using an automated segmentation algo-
rithm (Sudre et al., 2015) followed by visual quality con-
trol, including subcortical grey matter but excluding
infra-tentorial regions. APOE genotype was categorized
as e4-carrier or e4-non-carrier.
As previously described (Lu et al., 2019), childhood
cognitive ability was measured at 8 years (or 11 or
15 years if earlier data were missing) and highest educa-
tional qualification was recorded at 26 years—this was
converted to the equivalent years of full-time education,
for consistency with the FAD sample. Socioeconomic pos-
ition was derived from participant’s own occupation at
53 years, coded according to the UK Registrar General’s
Standard Occupational Classification, and categorized as
manual or non-manual.
Statistical analyses
As participants occasionally did not trace continuously
for 45 s as instructed, we excluded trials where the total
tracing time was <34.7 s (3 SD below the mean): 1.1
and 1.3% of trials from the FAD and Insight 46 data
sets, respectively (2 trials per participant).
Standard techniques were used to assess data normality
and model fit. A log transformation was applied to the
number of rotations, and a square-root transformation to
the number of errors per rotation, consistent with the
previously published studies (Say et al., 2011).
For tracing speed, tracing accuracy and subtraction
rate, we fitted multivariable regression models using gen-
eralized estimating equations, assuming a normal distribu-
tion for the dependent variable and an identity link, with
an exchangeable correlation structure and robust
Figure 1 Circle-tracing apparatus. This figure is reprinted from Say et al. (2011) with permission from Elsevier. The additional
box and cape to cover the participant’s arm in the indirect condition are not shown. The tablet displayed a 90-mm diameter circle and 5-mm
thick annulus; the monitor displayed a 143-mm diameter circle and 9-mm thick annulus. The tablet and monitor were positioned to achieve a
consistent horizontal diameter of 13 of visual angle. The red rectangle indicates the starting point from which participants were instructed to
begin tracing.
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standard errors to allow for the correlation between
repeated measures of the same participant.
For subtraction accuracy, a generalized estimating equa-
tions logistic regression model was used with an inde-
pendent correlation structure and robust standard errors.
The outcome was the number of incorrect responses,
treated as a proportion of the total number of responses.
For the FAD data set, model predictors were condition
(direct versus indirect), task (dual versus single), age, sex,
education and mutation status (carrier versus non-carrier).
For Insight 46, model predictors were condition (direct
versus indirect), age, sex, childhood cognitive ability, edu-
cation, socioeconomic position, handedness (left versus
right), amyloid status (positive versus negative), WHMV,
whole-brain volume and APOE-e4 (e4-carrier versus e4-
non-carrier). To adjust for the correlation between brain
volumes and head size, total intracranial volume was
included as a covariate. To investigate specific visuomotor
integration deficits (i.e. disproportionately poorer per-
formance in the indirect condition), we tested for interac-
tions between circle-tracing condition and predictors of
interest.
For the outcomes where statistically significant differen-
ces were observed between preclinical groups and con-
trols (i.e. circle-tracing accuracy and subtraction speed),
we conducted additional analyses to investigate whether
poorer performance was correlated with continuous meas-
ures of greater pathological burden. For FAD mutation
carriers, years to expected onset can be used as a proxy
for pathological burden; to investigate whether closer
proximity to expected onset predicted poorer perform-
ance, the models described above were re-run in mutation
carriers only with an additional predictor of years to
expected onset. In Insight 46 participants, we tested
whether greater burden of amyloid pathology was associ-
ated with poorer performance by rerunning the models
describe above, replacing dichotomized amyloid status
with continuous SUVR. We additionally refitted the mod-
els using a linear spline with a knot at the cut-point for
amyloid-positivity, to explore whether the slope differed
for amyloid-positive and amyloid-negative groups.
Regression coefficients for SUVR are quoted per 0.1
increment.
As speed–accuracy trade-offs have been noted on motor
tasks including circle-tracing (Nagengast et al., 2011;
Vaportzis et al., 2014; Peternel et al., 2017), we investi-
gated between-subject speed–accuracy trade-offs (i.e.
whether participants who traced more quickly tended to
trace less accurately, and whether participants who sub-
tracted more quickly tended to make more subtraction
errors). We calculated each participant’s mean number of
rotations, mean number of errors per rotation, mean sub-
traction rate and mean subtraction error rate across all
available trials, then used Pearson’s correlation (for circle-
tracing) and Spearman’s correlation (for subtraction—due
to highly skewed error rate) to examine the relationships
between the speed and the accuracy measures.
Supplementary Material describes about the investiga-
tion of ‘dual-task cost’ in FAD participants and compari-
son of performance between FAD and Insight 46
samples.
Analyses were conducted using Stata-15 (StataCorp).
Statistical significance was set at P< 0.05 for associations
and P< 0.1 for interactions.
Data availability
Insight 46 data are available via https://skylark.ucl.ac.uk/
NSHD/doku.php; accessed 29 January 2021. FAD data
are available on reasonable request.
Results
Participant characteristics and descriptive statistics for
outcome measures are listed in Table 1. For details of
performance on standard neuropsychological tests, see
Supplementary Material (FAD) and Lu et al. (2019)
(Insight 46).
As expected, tracing was slower and less accurate in
the indirect condition than the direct condition (Table 2
and Fig. 2). Despite tracing at a similar speed, FAD mu-
tation carriers traced less accurately than non-carriers;
this difference was exaggerated in the indirect condition,
although this interaction was not statistically significant
(interaction coefficient 0.18 [95% CIs: 0.04, 0.40]
P¼ 0.10) (Tables 1 and 2, Fig. 2A and see also
Supplementary Fig. 1A). In Insight 46 participants, there
was no overall association between amyloid status and
tracing speed or accuracy (Table 2), but there was an
interaction by which amyloid-positive participants traced
disproportionately less accurately (i.e. made more errors)
in the indirect condition (interaction coefficient 0.16
[95% CIs: 0.03, 0.29] P¼ 0.014) (Fig. 2B and see also
Supplementary Fig. 1B). Furthermore, both preclinical
groups were slower at subtraction, compared to control
groups, but did not significantly differ in subtraction ac-
curacy (Tables 1 and 2).
In Insight 46 participants, greater WMHV also pre-
dicted disproportionately poorer tracing accuracy in the
indirect condition, independently of amyloid (interaction
coefficient 0.10 [95% CIs: 0.01, 0.20], P¼ 0.037). In
addition, larger brain volume predicted faster tracing and
faster subtraction; higher childhood cognitive ability was
associated with faster and more accurate subtraction;
socioeconomic position and education had independent
effects on subtraction rate and accuracy respectively; and
males subtracted faster than females (Table 2).
As there is some evidence of sex differences in neural
control of complex movements (Gorbet and Sergio,
2007), and a previous study found that only females
showed an association between dementia risk (based on
family history of Alzheimer’s disease) and visuomotor in-
tegration impairments (Rogojin et al., 2019), we
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conducted a post hoc analysis to test whether males and
females differed in terms of the interaction between con-
dition and group on circle-tracing accuracy. In the FAD
sample, there was a three-way interaction between condi-
tion, group and sex (interaction coefficient ¼ 0.42
[95% CIs: 0.82, 0.02], P¼ 0.040), such that female
mutation carriers had disproportionately poorer tracing
accuracy in the condition of indirect visual feedback (esti-
mated interaction coefficient between condition and muta-
tion status for females ¼ 0.40 [0.12–0.67], P¼ 0.005),
but this effect was not seen among males (estimated
interaction coefficient between condition and mutation
status for males ¼ 0.02 [0.32 – 0.27], P¼ 0.88).
However, in the Insight 46 sample, there was no evidence
of such a sex difference (three-way interaction coefficient
between condition, sex, and amyloid status ¼ 0.07
[0.19, 0.32], P¼ 0.60), as males and females had simi-
lar estimated interaction coefficients between condition
and amyloid status (males: 0.19 [0.02, 0.37], P¼ 0.032;
females: 0.12 [0.06, 0.31], P¼ 0.19).
Associations with continuous
measures of pathological burden
There was also some evidence of associations between
continuous measures of greater pathological burden and
poorer circle-tracing accuracy. In FAD mutation carriers,
tracing accuracy decreased with closer proximity to
expected symptom onset, although the effect was not
statistically significant, likely due to the small sample size
[0.03 increase per year (errors per rotation, square-root
transformed) [95% CIs: 0.00, 0.07], P¼ 0.086]. In the
Insight 46 sample, results across the full range of SUVR
were consistent with the analyses using dichotomized
amyloid status: while there was no statistically significant
association between SUVR and tracing accuracy overall
(regression coefficient ¼ 0.051 [95% CIs: 0.006,
0.107], P¼ 0.079), there was an interaction by which
higher SUVR was associated with disproportionately
poorer tracing accuracy (i.e. more tracing errors) in the
condition of indirect visual feedback (interaction
Table 1 Participants’ characteristics and descriptive statistics for the circle-tracing task
FAD participantsa Insight 46 participantsa
Mutation carriers Non-carriers b-Amyloid positive b-Amyloid
negative
N 19 12 72 318
Sex: % female 47.4 50.0 45.8 49.7
Age (years)b: mean (SD) 39.0 (5.2) 39.7 (8.2) 70.6 (0.66) 70.6 (0.70)
Handedness: % right 100 100 88.9 90.9
Years to expected onset: mean (SD) 7.0 (4.5)
Years of education: mean (SD) 13.6 (2.6) 15.0 (2.4) 13.3 (2.1) 13.6 (2.1)
Childhood cognitive ability (Z-score)c: mean (SD) 0.43 (0.75) 0.41 (0.74)
Socioeconomic position: % manual 13.9 14.2












APOE genotype: % e4-carrier 61.1 23.6
TASKOUTCOMESd
Number of rotations: median (IQR)
Dual-task 7.8 (5.2–10.3) 6.4 (4.5–8.0) 4.4 (3.2–6.5) 4.4 (2.9–6.4)
Single-task 10.4 (6.3–12.8) 7.0 (5.7–10.0)
Errors per rotation: median (IQR)
Dual-task 0.95 (0.49–1.54) 0.32 (0.18–0.52) 0.94 (0.51–1.40) 0.73 (0.37–1.30)
Single-task 1.35 (1.09–1.95) 0.46 (0.33–0.88)
Subtraction rate (responses per second): median (IQR) 0.43 (0.24–0.58) 0.65 (0.46–0.75) 0.47 (0.39–0.55) 0.50 (0.37–0.63)
Subtraction error rate (%): median (IQR) 1.7 (0.5–5.4) 0.9 (0–1.8) 1.0 (0–3.5) 1.1 (0–2.9)
FAD, familial Alzheimer’s disease; IQR, interquartile range; SD, standard deviation; WMHV, white matter hyperintensity volume.
av2, two-tailed t-tests, and rank-sum tests were used to test for differences between the groups (mutation carriers versus non-carriers; amyloid-positive versus amyloid-negative)
for the demographic, biomarker and clinical variables: the only variable with a statistically significant difference was APOE-e4 between amyloid-positive and amyloid-negative
(P< 0.0001).
bFor Insight 46, age was calculated based on the date that the cognitive assessment was carried out [while assessments were typically completed on one day, 62 participants had to
have their scans rescheduled for a later date, with a median interval of 49 days (range, 1–216 days)].
cZ-scores for childhood cognitive ability were based on the full National Survey of Health and Development (NSHD) cohort of N¼ 5362, and hence the mean for Insight 46 partici-
pants indicates that they had higher childhood cognitive ability on average than their peers not recruited to this sub-study.
dAlthough statistical analyses were carried out on the trial-by-trial data, each participant’s mean score across trials was calculated for each outcome for the purposes of this table
(combined across the direct and indirect visual feedback conditions), to illustrate the distributions of performance.
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coefficient between SUVR and condition ¼ 0.087 [95%
CIs: 0.021, 0.153], P¼ 0.010). Re-running the model in
the indirect condition alone confirmed that higher SUVR
was associated with greater tracing errors in this condi-
tion (regression coefficient ¼ 0.091 [95% CIs: 0.021,
0.161], P¼ 0.010) and a spline analysis suggested that
the slope of this association was steeper in amyloid-posi-
tive individuals, although the associations were not statis-
tically significant in the amyloid groups separately
(amyloid-positive: regression coefficient ¼ 0.127 [95%
Table 2 Predictors of performance on circle-tracing and serial subtraction task in FAD and Insight 46 participants









































































































































































































































*Significant at P< 0.05.
**Significant at P< 0.01.
Multivariable regression models were used and hence each association is independent of all others. In addition to the predictors listed, the Insight 46 models also included total
intracranial volume and handedness. (Handedness was not applicable to the FAD models since all FAD participants were right-handed.)
FAD, familial Alzheimer’s disease; CI, confidence interval; WMHV, white matter hyperintensity volume.
aNumber of rotations was log-transformed and coefficients are expressed in exponentiated form, e.g. a coefficient of 1.5 would mean 50% more rotations.
bNumber of rotations per rotation was square-root transformed.
cSubtraction rate is in units of responses per second.
dOdds ratios >1 reflect higher error rates.
eThe coefficients for amyloid status are essentially unchanged if the model does not adjust for WMHV, whole-brain volume and APOE-e4.
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CIs: 0.016, 0.270], P¼ 0.082; amyloid-negative: regres-
sion coefficient ¼ 0.055 [95% CIs: 0.100, 0.210],
P¼ 0.488).
Higher SUVR also predicted slower subtraction rate in
Insight 46 participants (regression coefficient ¼ 0.025
[95% CIs: 0.045, 0.006], P¼ 0.010), and a spline
analysis revealed that the slope of this association differed
for amyloid-positive and amyloid-negative participants,
with higher SUVR associated with slower subtraction
among amyloid-positive participants (regression coefficient
¼ 0.037 [95% CIs: 0.074, 0.000], P¼ 0.047), but
not among amyloid-negative (regression coefficient ¼
0.014 [95% CIs: 0.055, 0.028], P¼ 0.522). However,
FAD mutation carriers showed no evidence of an associ-
ation between years to expected onset and subtraction
rate, (0.010 per year [95% CIs: 0.031, 0.014],
P¼ 0.441).
Speed–accuracy trade-offs
Speed-accuracy trade-offs were a notable feature of circle-
tracing performance in both the FAD and the Insight 46
samples, with a positive correlation between number of
rotations and number of errors per rotation (FAD:
r¼ 0.75, P< 0.0001; Insight 46: r¼ 0.45, P< 0.0001)
(Fig. 3). This indicates that participants tended to priori-
tize accuracy at the expense of speed, or vice versa,
consistent with the previously published studies
(Nagengast et al., 2011; Vaportzis et al., 2014; Peternel
et al., 2017). This may account for the counter-intuitive
association between older age and faster tracing in the
Insight 46 sample (Table 2), as there was a trend for
older participants to make more tracing errors
(P¼ 0.074, Table 2), suggesting that they may have
adopted a less cautious approach. Similarly, the associ-
ation between higher education and slower tracing in the
FAD sample (Table 2) should be interpreted in the con-
text of the association between higher education and
fewer tracing errors (P¼ 0.051, Table 2).
In contrast, no speed–accuracy trade-off was observed
for subtraction; in fact, there was a negative correlation
between subtraction rate and subtraction error rate in
both samples (FAD: q ¼ 0.59, P¼ 0.0008; Insight 46:
q ¼ 0.48, P< 0.0001) (Fig. 3). This indicates that par-
ticipants who found subtraction relatively difficult tended
to be both slower and more error-prone.
Discussion
To our knowledge, this is the first study to report an as-
sociation between b-amyloid pathology and visuomotor
integration deficits, and also the first to show that such
deficits may be common to familial and sporadic
Figure 2 Circle-tracing errors in the conditions of direct and indirect visual feedback for (A) FAD mutation carriers versus
non-carriers, (B) amyloid-positive versus amyloid-negative older adults. Plots show marginal means and 95% confidence intervals from
the multivariable regression models. *Mutation carriers made more errors than non-carriers overall (P-value is for the main effect of mutation
status from the regression model reported in Table 2). †The increase in errors in the indirect condition (compared to the direct condition) was
greater in the preclinical Alzheimer’s groups (FAD mutation carriers; amyloid-positive) than controls (non-carriers; amyloid-negative) (P-values
are for interaction tests between group and condition, from the multivariable regression models). This figure may be compared with Fig. 2B in
Say et al. (2011), which shows a similar pattern in presymptomatic Huntington’s disease: the equivalent square-root-transformed values for
presymptomatic Huntington’s mutation carriers (on average 8.7 years from expected onset) were 0.5 versus 1.2 (direct versus indirect),
compared to controls with 0.5 versus 0.9 (direct versus indirect). In (B), the plotted means and the P-values are identical to two decimal
places if the model does not include adjustment for WMHV, whole-brain volume and APOE-e4. See Supplementary Fig. 1 for a version of this
graph that includes individual-level data.
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preclinical Alzheimer’s disease. As hypothesized, both pre-
clinical groups (FAD mutation carriers; amyloid-positive
older adults) showed evidence of subtly impaired visuo-
motor integration, indicated by disproportionately poorer
circle-tracing accuracy when visual feedback was indirect,
although results for the familial group should be inter-
preted with caution due to low statistical power. This
mirrors the result in presymptomatic Huntington’s muta-
tion carriers (Say et al., 2011). Although speed–accuracy
trade-offs were observed as expected on the circle-tracing
task, this does not explain the poorer accuracy of the
preclinical groups, since we did not find evidence of
group differences in tracing speed.
Despite the different age profiles of the two groups,
individuals within them who will go on to develop
Alzheimer’s disease may be at similar points along the
preclinical continuum: FAD mutation carriers were on
average 7 years before expected symptom onset, and
Insight 46 participants (age, 70 years) were around a
decade away from the average age of onset of sporadic
Alzheimer’s disease [76 years in APOE-e4 homozygotes,
84 years in e4-non-carriers (Liu et al., 2013)]. Regarding
whether these early deficits in visuomotor integration
may precede other cognitive changes, mutation carriers
performed normally on most standard tests—the only
exceptions being, interestingly, tasks with similar spatial
transformation cognitive demands to circle-tracing
(Supplementary Material). Their predominantly normal
cognitive performance and lack of observed memory defi-
cits are consistent with a longitudinal analysis from the
Dominantly Inherited Alzheimer Network which found
that decline on a cognitive composite did not emerge
Figure 3 Relationships between speed and accuracy for circle-tracing and subtraction in the FAD (n 5 31) and Insight 46
(n 5 390) samples. Markers show each participant’s mean across all trials. A speed–accuracy trade-off was observed for circle-tracing, as there
was a positive correlation between number of rotations and number of errors per rotation (A and B). For the subtraction task, faster
subtraction correlated with lower error rate (C and D). Correlation coefficients for each group were as follows: (A) (mutation carriers r ¼
0.77, P ¼ 0.0001; non-carriers r ¼ 0.86, P ¼ 0.0004); (B) (amyloid-positive r ¼ 0.23, P ¼ 0.0499; amyloid-negative r ¼ 0.49, P < 0.0001); (C)
(mutation carriers q ¼ 0.63, P ¼ 0.0035; non-carriers q ¼ 0.43, P ¼ 0.21); (D) (amyloid-positive q ¼ 0.50, P < 0.0001; amyloid-negative q
¼ 0.49, P < 0.0001).
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until 3 years before expected symptom onset (McDade
et al., 2018). Also, the majority of mutation carriers in
our sample carried PSEN1 mutations, which are associ-
ated with less medial temporal lobe atrophy and more
cortical loss than APP mutations or sporadic Alzheimer’s
disease (Pilotto et al., 2013; Scahill et al., 2013). In con-
trast, amyloid-positive Insight 46 participants showed
subtle deficits in memory, non-verbal reasoning, and con-
sistency of reaction time (Lu et al., 2019, 2020). Their
visuomotor integration deficit (i.e. the mean difference be-
tween amyloid-positive and amyloid-negative groups in
circle-tracing accuracy with indirect visual feedback—
equivalent to 0.35 SD) was of a similar magnitude to
their deficits in non-verbal reasoning (0.39 SD) and reac-
tion time consistency (0.37 SD), but greater than on the
Preclinical Alzheimer Cognitive Composite (0.17 SD) (Lu
et al., 2019, 2020).
A notable difference between the two samples was that
FAD mutation carriers traced less accurately than non-
carriers across the whole task, whereas for amyloid-posi-
tive older adults their deficit was restricted to the condi-
tion of indirect feedback. This could reflect the higher
reported prevalence of neurological and movement abnor-
malities (e.g. myoclonus and pyramidal signs) in familial
compared to sporadic Alzheimer’s disease, although
debates continue over the extent of such phenotypic dif-
ferences (Joshi et al., 2012; Tang et al., 2016; Vöglein
et al., 2019).
While this was a cross-sectional study, our results
imply that this task may have potential for tracking de-
cline, as greater burden of amyloid pathology (continuous
measure) correlated with greater visuomotor integration
difficulties and slower subtraction, with evidence that
these associations may be stronger in amyloid-positive
participants. Similarly, visuomotor integration in FAD
mutation carriers appeared to be worse with closer prox-
imity to expected onset, although this was inconclusive
due to the small sample size. Another potential advantage
of circle-tracing as a measure of subtle cognitive decline
is its apparent independence from general cognitive abil-
ity; in Insight 46, childhood cognitive ability has consist-
ently predicted performance on diverse cognitive measures
across the life-course (Lu et al., 2019; Richards et al.,
2019), and hence its lack of association with circle-trac-
ing performance is notable. Finally, this type of task has
applicability to daily functioning, as visuomotor integra-
tion is intrinsic to many everyday activities—for example,
subtle visuomotor difficulties may be relevant to declines
in driving abilities in older adults with preclinical
Alzheimer’s disease (Roe et al., 2019).
Our finding that white matter disease was associated
with poorer visuomotor integration—independently of
amyloid—is consistent with the previous evidence relating
lower white matter integrity to poorer visuomotor inte-
gration (Hawkins et al., 2015). While participants were
at an age where accelerated brain atrophy is still rare, we
also found associations between brain volume and three
diverse speed measures: circle-tracing speed, subtraction
rate and Digit-Symbol Substitution [the latter reported by
Lu et al. (2019)], consistent with the previous studies
including in younger adults (Magistro et al., 2015;
Takeuchi et al., 2017).
Interpretation of our finding of slower subtraction in
both preclinical groups is limited by the fact that we did
not measure subtraction in isolation in Insight 46, and
hence cannot quantify the extent to which this result
reflects poorer subtraction ability versus ‘dual-task cost’,
which has previously been proposed as a sensitive marker
of preclinical Alzheimer’s disease (MacPherson et al.,
2012). We hypothesize that both had an impact, given
that FAD mutation carriers under-performed on an arith-
metic task with a speed element, and showed dual-task
costs on circle-tracing speed (Supplementary Material).
This will be addressed in the next phase of Insight 46
with direct evaluation of single-task circle tracing and
subtraction.
Strengths and limitations relating to the Insight 46 co-
hort have been discussed previously, key strengths being
its population-based nature, very narrow age range and
large sample size, and limitations being that the sample is
entirely white and biased towards those with socioeco-
nomic and health advantages (James et al., 2018; Lu
et al., 2019). The lack of measures of tau pathology
(which will be addressed in longitudinal data collection)
limits conclusions about the pathological basis for visuo-
motor changes. The relatively small sample size of the
FAD sample, due to the rarity of FAD mutations, limited
statistical power to detect differences between mutation
carriers and non-carriers, and limits comparisons between
the FAD and Insight 46 samples.
Conclusion
In summary, this study provides novel evidence of com-
mon visuomotor integration deficits in familial and spor-
adic preclinical Alzheimer’s disease, several years before
expected symptom onset. Visuomotor integration tasks
may hold promise as sensitive measures of disease-related
cognitive decline.
Supplementary Material
Supplementary material is available at Brain
Communications online.
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